Analysis of multiple endpoints in clinical trials

Ajit C Tamhane, Alex Dmitrienko

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Scopus citations

Abstract

Most human diseases are characterized by multidimensional etiology and the efficacy of an experimental treatment frequently needs to be assessed on multiple outcome measures - commonly referred to as endpoints. There is a variety of ways in which the contribution of each endpoint can be accounted for in the primary analysis, for example, the trial’s sponsor can treat endpoints as independent entities or as manifestations of a single underlying cause. The following examples illustrate the common approaches to analyzing multiple endpoints.

Original languageEnglish (US)
Title of host publicationMultiple Testing Problems in Pharmaceutical Statistics
PublisherCRC Press
Pages131-165
Number of pages35
ISBN (Electronic)9781584889854
ISBN (Print)9781584889847
StatePublished - Jan 1 2009

ASJC Scopus subject areas

  • Mathematics(all)
  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Analysis of multiple endpoints in clinical trials'. Together they form a unique fingerprint.

Cite this